Development of a prognostic prediction model for non-smoking lung adenocarcinoma based on pathological information and laboratory hematologic indicators: a multicenter study

  • 0State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.

|

|

Summary

This summary is machine-generated.

A new prognostic model accurately predicts survival in non-smoking lung adenocarcinoma patients using tumor stage, size, and simple blood markers. This model aids personalized treatment decisions for lung cancer patients.

Area Of Science

  • Oncology
  • Medical Diagnostics
  • Biostatistics

Background

  • Lung adenocarcinoma is a leading cause of cancer death.
  • Accurate prognostic models are crucial for non-smoking patients.
  • Existing models may not fully integrate hematologic indicators.

Purpose Of The Study

  • To develop a practical prognostic model for non-smoking lung adenocarcinoma patients.
  • To combine pathological information with hematologic indicators for survival prediction.
  • To establish a nomogram for evaluating prognostic impact.

Main Methods

  • Retrospective analysis of 1,172 non-smoking lung adenocarcinoma patients.
  • Cox univariate and multivariate analyses to identify significant variables.
  • Construction of a Cox proportional hazards model and a nomogram.

Main Results

  • Multivariate analysis identified tumor TNM stage, size, WBC count, neutrophil%, lymphocyte%, and hemoglobin as significant predictors.
  • The model demonstrated strong predictive performance with C-indices of 0.811 (training), 0.786 (test), and 0.810 (validation).
  • AUC values for 3- and 5-year overall survival were consistently high across datasets, indicating effective outcome discrimination.

Conclusions

  • A prognostic model integrating tumor characteristics and hematologic markers effectively predicts survival in non-smoking lung adenocarcinoma.
  • The model's indicators are readily available and require no conversion, simplifying clinical application.
  • This provides a valuable tool for personalized diagnosis and treatment strategies in clinical practice.